Papers presented at events
Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
Fecha
2022Registro en:
SILVA, N. C. G. et al. Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 51.
10.35259/isi.2022_52282
Autor
Silva, Natália Cristina Gomes da
Viveiros, Diana Dalzy
Almeida, Carlos Eduardo Bonacossa de
Arissawa, Marcia
Missailidis, Sotiris